欧洲卵巢癌诊断和治疗市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

欧洲卵巢癌诊断和治疗市场按癌症类型(上皮卵巢肿瘤、卵巢生殖细胞肿瘤等)、模式(诊断和治疗)和地理划分。

市场快照

Cancer 1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 8.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

推动欧洲卵巢癌诊断和治疗市场的主要因素是增加老年妇女人口、增加卵巢癌病例以及更多地使用联合疗法治疗卵巢癌。卵巢癌的发病率在 55-64 岁之间的女性中很高。卵巢癌的主要症状包括腹胀、盆腔和腹痛、进食困难和泌尿系统症状。根据英国癌症研究中心的数据,卵巢癌是欧洲女性第五大常见癌症。此外,根据 Globocan 的估计,欧洲在 2018 年记录了 67,771 例新的卵巢癌病例,其中 44,576 人死亡。随着癌症负担的增加,对有效治疗的需求也在增加。因此,由于这些因素,预计市场在预测期内将出现显着增长。

报告范围

根据报告的范围,卵巢癌是由卵巢组织中不受控制的细胞生长引起的。这是一个日益严重的问题,也是女性最常见的死亡原因之一。

By Cancer Type
Epithelial Ovarian Tumors
Ovarian Germ Cell Tumors
Others
By Modality
Diagnosis
Biopsy
Blood Tests
Ultrasound
PET
CT Scan
Other Diagnosis
Therapeutics
Chemotherapy
Radiation Therapy
Immunotherapy
Hormonal Therapy
Others
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

主要市场趋势

化疗有望占据欧洲卵巢癌诊断和治疗市场的最大份额

化疗是用于阻止或减缓癌细胞生长的最常见的治疗形式。手术和放射疗法通过去除、杀死或破坏特定区域的癌细胞起作用,但化学疗法在整个身体中起作用。这意味着化学疗法可以杀死和破坏已经扩散到远离原始肿瘤的身体其他部位的癌细胞。几十年来,基于化疗的药物一直是治疗的选择,并且已成为几种癌症的主要治疗选择。因此,由于上述因素,随着卵巢癌负担的增加,预计化疗市场将在预测期内增长。

Europe Ovarian Cancer Diagnostics and Therapeutics Market 3.png

竞争格局

欧洲卵巢癌诊断和治疗市场由几个主要参与者组成。这些公司正在实施某些战略举措,例如并购、新产品发布和合作伙伴关系,以帮助他们加强市场地位。例如,2019 年,百时美施贵宝公司收购了 Celgene,从而拓宽了公司在肿瘤学、血液学、免疫学和心血管疾病领域的产品线。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Ovarian Cancer

      2. 4.2.2 Greater Use of Combination Therapies for the Treatment of Ovarian Cancer

      3. 4.2.3 Rising Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Accurate Diagnosis of Ovarian Cancer

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Cancer Type

      1. 5.1.1 Epithelial Ovarian Tumors

      2. 5.1.2 Ovarian Germ Cell Tumors

      3. 5.1.3 Others

    2. 5.2 By Modality

      1. 5.2.1 Diagnosis

        1. 5.2.1.1 Biopsy

        2. 5.2.1.2 Blood Tests

        3. 5.2.1.3 Ultrasound

        4. 5.2.1.4 PET

        5. 5.2.1.5 CT Scan

        6. 5.2.1.6 Other Diagnosis

      2. 5.2.2 Therapeutics

        1. 5.2.2.1 Chemotherapy

        2. 5.2.2.2 Radiation Therapy

        3. 5.2.2.3 Immunotherapy

        4. 5.2.2.4 Hormonal Therapy

        5. 5.2.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 Europe

        1. 5.3.1.1 Germany

        2. 5.3.1.2 United Kingdom

        3. 5.3.1.3 France

        4. 5.3.1.4 Italy

        5. 5.3.1.5 Spain

        6. 5.3.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amneal Pharmaceuticals LLC

      2. 6.1.2 Astrazeneca plc

      3. 6.1.3 Boehringer Ingelheim International GmbH

      4. 6.1.4 Bristol Myers Squibb Company

      5. 6.1.5 Eli Lilly and Company

      6. 6.1.6 F. Hoffman-La Roche Ltd

      7. 6.1.7 Glaxosmithkline Plc

      8. 6.1.8 Johnson and Johnson (Janssen Pharmaceuticals)

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Siemens Healthineers AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Ovarian Cancer Diagnostics and Therapeutics Market market is studied from 2018 - 2026.

The Europe Ovarian Cancer Diagnostics and Therapeutics Market is growing at a CAGR of 8.6% over the next 5 years.

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Glaxosmithkline Plc, Johnson and Johnson (Janssen Pharmaceuticals), Eli Lilly and Company are the major companies operating in Europe Ovarian Cancer Diagnostics and Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!